sec filing
KA
AMEX · KAPA
Kairos Pharma, Ltd.
Healthcare · Biotechnology
$1.56
Down-$0.08 (-4.88%)
Updated Oct 2, 2026, 6:34 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 16.86M
- P/E ratio
- -3.24
- Dividend yield
- 0.00%
- 52-week range
- $0.22 – $1.91
- Volume
- 79.13K
- Avg. volume
- 529.54K
Price performance · KAPA
KAPA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 1, 2026
KAPA closed at $1.56 after 20 trading sessions, down 6.59% for the selected period.
- Last close
- $1.56
- Period change
- -6.59%
- Period low
- $1.56
- Period high
- $1.85
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 1, 2026 | $1.59 | $1.65 | $1.47 | $1.56 | 79.13K |
| Sep 30, 2026 | $1.71 | $1.78 | $1.60 | $1.64 | 99.47K |
| Sep 29, 2026 | $1.68 | $1.7552 | $1.64 | $1.66 | 53.28K |
| Sep 28, 2026 | $1.74 | $1.798 | $1.6503 | $1.68 | 53.5K |
| Sep 25, 2026 | $1.77 | $1.7799 | $1.72 | $1.72 | 42.32K |
| Sep 24, 2026 | $1.70 | $1.82 | $1.695 | $1.77 | 300.91K |
| Sep 23, 2026 | $1.75 | $1.7775 | $1.70 | $1.73 | 63.38K |
| Sep 22, 2026 | $1.78 | $1.81 | $1.70 | $1.78 | 247.93K |
| Sep 21, 2026 | $1.75 | $1.80 | $1.70 | $1.79 | 126.88K |
| Sep 18, 2026 | $1.81 | $1.84 | $1.72 | $1.73 | 168.74K |
| Sep 17, 2026 | $1.84 | $1.84 | $1.78 | $1.81 | 33.86K |
| Sep 16, 2026 | $1.84 | $1.84 | $1.81 | $1.81 | 5.53K |
| Sep 15, 2026 | $1.79 | $1.89 | $1.76 | $1.85 | 38.05K |
| Sep 14, 2026 | $1.70 | $1.86 | $1.70 | $1.84 | 53.54K |
| Sep 11, 2026 | $1.6866 | $1.765 | $1.67 | $1.758 | 33.2K |
| Sep 10, 2026 | $1.69 | $1.73 | $1.6206 | $1.68 | 32.6K |
| Sep 9, 2026 | $1.76 | $1.80 | $1.66 | $1.66 | 81.9K |
| Sep 8, 2026 | $1.85 | $1.89 | $1.77 | $1.77 | 174.36K |
| Sep 4, 2026 | $1.67 | $1.91 | $1.66 | $1.84 | 306.73K |
| Sep 3, 2026 | $1.55 | $1.6899 | $1.55 | $1.67 | 47.9K |
Latest KAPA news
The latest Smart Investors Daily articles mentioning KAPA.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…